Skip to main content
Clinical Trials/NCT01502449
NCT01502449
Unknown
Not Applicable

Randomized Trial of Telephonic Psychotherapy and Case Management for Combat-Related Posttraumatic Stress Disorder

Uniformed Services University of the Health Sciences1 site in 1 country91 target enrollmentJanuary 2012
ConditionsPTSD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
PTSD
Sponsor
Uniformed Services University of the Health Sciences
Enrollment
91
Locations
1
Primary Endpoint
Posttraumatic Stress Disorder Checklist - Civilian Version (PCL)
Last Updated
14 years ago

Overview

Brief Summary

This study will evaluate a telephone-delivered cognitive-behavioral psychotherapy intervention designed for primary care treatment of combat-exposed service members with PTSD. The investigators will assess Posttraumatic Stress Disorder (PTSD) symptoms, mental health-related and occupational functioning, and symptoms of depression, anxiety, and somatization.

Detailed Description

This is a randomized controlled trial that will compare DESTRESS-T to Optimized Usual Care (OUC). Optimized Usual Care is usual primary care PTSD treatment, plus a telephone care management program that includes: four outreach calls, feedback to the treating primary care provider (PCP), and care coordination.

Registry
clinicaltrials.gov
Start Date
January 2012
End Date
January 2014
Last Updated
14 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Charles Engel

Dir., Deployment Health Clinical Center; Associate Professor, psychiatry, USUHS

Uniformed Services University of the Health Sciences

Eligibility Criteria

Inclusion Criteria

  • Age\>18 years
  • DSM-IV diagnosis of PTSD (derived from the CAPS) due to combat in OIF/OEF deployment
  • Active duty personnel

Exclusion Criteria

  • Active suicidal or violent ideation within the past two months as assessed by the MINI and a supplementary form developed by the project team (see Appendices)
  • Current participation in any active psychotherapy (e.g., psychoanalysis, CBT) for mood, anxiety or substance use disorders (as determined via service member self report and/or check of medical record)
  • Recurrent PTSD treatment failure in psychotherapy, as determined via consensus of study team members (Dr. Charles Engel, Dr. Brett Litz, and Dr. Kristie Gore)
  • Current alcohol dependence, as assessed by MINI
  • Acute psychosis, psychotic episode, or psychotic disorder diagnosis within the past year, as assessed by the MINI
  • Currently on an antipsychotic or mood-stabilizing agent for bipolar disorder or any disorder with psychotic features, as determined by medical record and/or self report
  • Unstable administration schedule or dosing of any antidepressant, anxiolytic, or sedative-hypnotic (i.e., will exclude for any related medication changes in the month prior to randomization), as determined by medical record or service member self report
  • Acute or unstable physical illness based on the judgment of the patient's primary care clinician and the study team.

Outcomes

Primary Outcomes

Posttraumatic Stress Disorder Checklist - Civilian Version (PCL)

Time Frame: Baseline, 12 weeks, 18 weeks, and 24 weeks

Symptoms of PTSD will be assessed using the PTSD Checklist-Civilian Version. The PCL is a self-report measure developed for measuring PTSD symptom severity and for estimating PTSD caseness when administration of a structured clinical interview is not feasible. Respondents rate PCL items on a 5-point scale ("not at all" through "extremely") to indicate the degree to which they have been bothered by each of 17 PTSD symptoms during the past month. Possible PCL scores range from 17 to 85.

Secondary Outcomes

  • Medical Outcomes Survey Short-Form-12 (SF-12)(Baseline, 12 weeks, 18 weeks, and 24 weeks)
  • World Health Organization Health & Work Performance Questionnaire (HPQ)(Baseline, 12 weeks, 18 weeks, and 24 weeks)
  • Patient Health Questionnaire (PHQ)(Baseline, 12 weeks, 18 weeks, and 24 weeks)
  • Generalized Anxiety Symptom Severity (GAD-7)(Baseline)
  • Sheehan Disability Scale (SDS)(baseline, 12 week, 18 week and 24 week)
  • Alcohol Use Disorders Identification Test-Civilian version (AUDIT-C)(baseline, 12 week, 18 week, and 24 week)
  • Numeric Rating Scale for Pain (NRS).(baseline, 12 week, 18 week, and 24 week)

Study Sites (1)

Loading locations...

Similar Trials